Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(25%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
2
25%
Ph phase_4
4
50%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 4Post-market surveillance
4(57.1%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(3)
Other(1)

Detailed Status

Completed3
Not yet recruiting2
Recruiting1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 44 (57.1%)
N/A2 (28.6%)

Trials by Status

recruiting113%
completed338%
not_yet_recruiting225%
unknown113%
active_not_recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8